Drugs Made In America Acquisition II Corp. Unit DMIIU NASDAQ

NASDAQ Global Select • Financial Services • Asset Management • US • USD

Drugs Made In America Acquisition II Corp. Unit (DMIIU) est une Asset Management entreprise du Services Financiers secteur, actuellement cotée à $10.06.

Stock Chart & Stats

Données de Marché

Plage 52 semaines9.935-10.8

Volume1K

Volume Moyen (30J)3.69K

Cap. Boursière$633.96M

Bêta (1 an)0.24

IPO Date2025-09-25

Employees2

CEORoger Bendelac

Financial Highlights & Ratios

Analyst Forecast

Informations sur l'Entreprise

PaysUS

BourseNASDAQ Global Select

DeviseUSD

ISINKYG2851K1206

Price Chart

DMIIU

Drugs Made In America Acquisition II Corp. Unit ↗ · NASDAQ Global Select

Financial Services • Asset Management

9.94 52WK RANGE 10.80

Les autres consultent aussi

GAM

General American Investors Company, Inc.

$62.90

+0.61%

NCDL

Nuveen Churchill Direct Lending Corp.

$14.42

+2.85%

GAIN

Gladstone Investment Corporation

$15.36

+1.45%

MSIF

MSC Income Fund, Inc.

Eagle Point Income Company Inc.

$9.82

+1.45%

OCCI

OFS Credit Company, Inc.

$2.98

-1.65%

VITSX

Vanguard Total Stock Market Index Fund Institutional Shares

$166.82

+1.15%

Drugs Made In America Acquisition II Corp. Unit DMIIU NASDAQ

Stock Chart & Stats

Price Chart

Les autres consultent aussi

Alertes Actions Sous-évaluées